Clinical Trials · NCT00003057

Octreotide Compared With Loperamide Hydrochloride for Chemotherapy-Related Diarrhea in Patients With Colorectal Cancer

CompletedPhase 3Octreotide (Approved)
Phase
Phase 3
Recruitment status
Completed
Sponsor
Eastern Cooperative Oncology Group
Enrollment
500
Start date
Mar 1997
Locations
33 sites, United States
Primary endpoint
Study in Colorectal Cancer
View Octreotide compound reference